Pricing Log in Create free account
Friday 6 November 2026 Export NBIX’s income statement to Excel — free account

Neurocrine Biosciences, Inc.

NBIX Healthcare Drug Manufacturers Specialty & Generic

Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.

Revenue
+41.2%
EPS
−3.67%
Free cash flow
+79.0%

Quarter to September 2026, against a year earlier

163.18 3.42 +2.14%
Market cap
$16.2B
P/E
23.0×
Fwd P/E
20.6×
Dividend yield
—
F-score
7/9
Altman Z
7.80
Beneish M
−2.64
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Neurocrine Biosciences, Inc. (NBIX) Current ratio

Alert me on Current ratio

Neurocrine Biosciences, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.0×, down 1.4× from fiscal 2025 (3.4×). Over the past ten years it has ranged from 1.5× (fiscal 2019) to 14.9× (fiscal 2015); the current reading is higher than 36% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 3.4× (0.11%)
FY2024 3.4× 38.42%
FY2023 2.5× (9.21%)
FY2022 2.7× (31.70%)
FY2021 4.0× (27.37%)
FY2020 5.4× 270.67%
FY2019 1.5× (82.42%)
FY2018 8.4× (17.99%)
FY2017 10.2× (0.11%)
FY2016 10.2× (31.66%)

Quarterly newest first

Period Current ratio Change
Sep 2026 2.0× 8.92%
Jun 2026 1.9× (36.07%)
Mar 2026 2.9× (13.68%)
Dec 2025 3.4× 0.31%
43 more quarters

Against its own ten years

Low 1.5× High 14.9×
Ten-year median 4.0×
Current reading's percentile 36

Current ratio against peers

Company Current ratio
UTHR United Therapeutics Corporation compare 4.7×
KNSA Kiniksa Pharmaceuticals International, plc compare 3.9×
ZTS Zoetis Inc. compare 3.1×
ALKS Alkermes plc compare 2.4×
ELAN Elanco Animal Health Incorporated compare 2.1×
NBIX Neurocrine Biosciences, Inc. 2.0×
RDY Dr. Reddy's Laboratories Ltd compare 1.9×
VTRS Viatris Inc. compare 1.6×
HLN Haleon PLC Sponsored ADR compare 0.7×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on NBIX